136 related articles for article (PubMed ID: 15251211)
1. Over-production of dihydrofolate reductase leads to sulfa-dihydropteroate resistance in yeast.
Patel O; Karnik K; Macreadie IG
FEMS Microbiol Lett; 2004 Jul; 236(2):301-5. PubMed ID: 15251211
[TBL] [Abstract][Full Text] [Related]
2. Inhibition studies of sulfonamide-containing folate analogs in yeast.
Patel O; Satchell J; Baell J; Fernley R; Coloe P; Macreadie I
Microb Drug Resist; 2003; 9(2):139-46. PubMed ID: 12820798
[TBL] [Abstract][Full Text] [Related]
3. Plasmodium vivax dihydrofolate reductase as a target of sulpha drugs.
Djapa LY; Zelikson R; Delahodde A; Bolotin-Fukuhara M; Mazabraud A
FEMS Microbiol Lett; 2006 Mar; 256(1):105-11. PubMed ID: 16487326
[TBL] [Abstract][Full Text] [Related]
4. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use.
Ma L; Borio L; Masur H; Kovacs JA
J Infect Dis; 1999 Dec; 180(6):1969-78. PubMed ID: 10558954
[TBL] [Abstract][Full Text] [Related]
5. Folic acid utilisation related to sulfa drug resistance in Saccharomyces cerevisiae.
Bayly AM; Berglez JM; Patel O; Castelli LA; Hankins EG; Coloe P; Hopkins Sibley C; Macreadie IG
FEMS Microbiol Lett; 2001 Nov; 204(2):387-90. PubMed ID: 11731153
[TBL] [Abstract][Full Text] [Related]
6. Dihydropteroate synthase mutations in Pneumocystis jiroveci can affect sulfamethoxazole resistance in a Saccharomyces cerevisiae model.
Iliades P; Meshnick SR; Macreadie IG
Antimicrob Agents Chemother; 2004 Jul; 48(7):2617-23. PubMed ID: 15215118
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological study of sulfonamide and trimethoprim resistance genes in Enterobacteriaceae.
Panbangred W; Jayanetra P; Pilantanapak A
Southeast Asian J Trop Med Public Health; 1990 Jun; 21(2):175-84. PubMed ID: 2237584
[TBL] [Abstract][Full Text] [Related]
8. Vitamin B3 confers resistance to sulfa drugs in Saccharomyces cerevisiae.
Kornfeld O; Nichols BP
FEMS Microbiol Lett; 2005 Oct; 251(1):137-41. PubMed ID: 16112818
[TBL] [Abstract][Full Text] [Related]
9. Promoter strength of folic acid synthesis genes affects sulfa drug resistance in Saccharomyces cerevisiae.
Iliades P; Berglez J; Meshnick S; Macreadie I
Microb Drug Resist; 2003; 9(3):249-55. PubMed ID: 12959403
[TBL] [Abstract][Full Text] [Related]
10. Pneumocystis jiroveci dihydropteroate synthase polymorphisms confer resistance to sulfadoxine and sulfanilamide in Saccharomyces cerevisiae.
Meneau I; Sanglard D; Bille J; Hauser PM
Antimicrob Agents Chemother; 2004 Jul; 48(7):2610-6. PubMed ID: 15215117
[TBL] [Abstract][Full Text] [Related]
11. Genetic diversity of drug targets including dihydropteroate synthase, dihydrofolate reductase and cytochrome b, in Pneumocystis carinii f. sp. hominis isolates in Japan.
Takahashi T; Kanda T; Iwamoto A
Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):159-76. PubMed ID: 15080506
[TBL] [Abstract][Full Text] [Related]
12. Mutations of Pneumocystis jirovecii dihydrofolate reductase associated with failure of prophylaxis.
Nahimana A; Rabodonirina M; Bille J; Francioli P; Hauser PM
Antimicrob Agents Chemother; 2004 Nov; 48(11):4301-5. PubMed ID: 15504856
[TBL] [Abstract][Full Text] [Related]
13. A rapid assay for dihydropteroate synthase activity suitable for identification of inhibitors.
Fernley RT; Iliades P; Macreadie I
Anal Biochem; 2007 Jan; 360(2):227-34. PubMed ID: 17134675
[TBL] [Abstract][Full Text] [Related]
14. Two mutations in dihydrofolate reductase combined with one in the dihydropteroate synthase gene predict sulphadoxine-pyrimethamine parasitological failure in Ugandan children with uncomplicated falciparum malaria.
Talisuna AO; Nalunkuma-Kazibwe A; Langi P; Mutabingwa TK; Watkins WW; Van Marck E; Egwang TG; D'Alessandro U
Infect Genet Evol; 2004 Dec; 4(4):321-7. PubMed ID: 15374529
[TBL] [Abstract][Full Text] [Related]
15. Antifolate screening using yeast expressing Plasmodium vivax dihydrofolate reductase and in vitro drug susceptibility assay for Plasmodium falciparum.
Djapa LY; Basco LK; Zelikson R; Rosowsky A; Djaman JA; Yonkeu JN; Bolotin-Fukuhara M; Mazabraud A
Mol Biochem Parasitol; 2007 Nov; 156(1):89-92. PubMed ID: 17727978
[TBL] [Abstract][Full Text] [Related]
16. [Research progress on genes mutations related to sulfa drug resistance in
Wang M; Zhu B
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2017 May; 46(5):563-569. PubMed ID: 29488726
[TBL] [Abstract][Full Text] [Related]
17. Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children.
Tahar R; Basco LK
Acta Trop; 2007 Aug; 103(2):81-9. PubMed ID: 17640607
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the Pneumocystis jirovecii DHPS gene confer cross-resistance to sulfa drugs.
Iliades P; Meshnick SR; Macreadie IG
Antimicrob Agents Chemother; 2005 Feb; 49(2):741-8. PubMed ID: 15673759
[TBL] [Abstract][Full Text] [Related]
19. The implication of dihydrofolate reductase and dihydropteroate synthetase gene mutations in modification of Plasmodium falciparum characteristics.
A-Elbasit IE; Alifrangis M; Khalil IF; Bygbjerg IC; Masuadi EM; Elbashir MI; Giha HA
Malar J; 2007 Aug; 6():108. PubMed ID: 17686173
[TBL] [Abstract][Full Text] [Related]
20. Plasmodium falciparum dhfr but not dhps mutations associated with sulphadoxine-pyrimethamine treatment failure and gametocyte carriage in northern Ghana.
Mockenhaupt FP; Teun Bousema J; Eggelte TA; Schreiber J; Ehrhardt S; Wassilew N; Otchwemah RN; Sauerwein RW; Bienzle U
Trop Med Int Health; 2005 Sep; 10(9):901-8. PubMed ID: 16135198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]